MeiraGTx Holdings plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MGTX research report →
Companywww.meiragtx.com
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program.
- CEO
- Alexandria Forbes
- IPO
- 2018
- Employees
- 375
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $887.20M
- P/E
- -6.46
- P/S
- 11.12
- P/B
- -13.40
- EV/EBITDA
- -9.70
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 91.64%
- Op Margin
- -131.89%
- Net Margin
- -151.12%
- ROE
- 474.91%
- ROIC
- -109.97%
Growth & Income
- Revenue
- $81.39M · 144.57%
- Net Income
- $-114,201,000 · 22.73%
- EPS
- $-1.42 · 33.02%
- Op Income
- $-105,968,000
- FCF YoY
- 54.15%
Performance & Tape
- 52W High
- $11.85
- 52W Low
- $4.82
- 50D MA
- $9.01
- 200D MA
- $8.21
- Beta
- 1.24
- Avg Volume
- 786.05K
Get TickerSpark's AI analysis on MGTX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 26 | Forbes Alexandria | sell | 62,000 |
| May 13, 26 | Fleck Penny Renee | other | 100,000 |
| May 13, 26 | Fleck Penny Renee | other | 100,000 |
| May 11, 26 | Fleck Penny Renee | other | 0 |
| Jan 7, 26 | Zeldin Robert K | other | 7,814 |
| Apr 17, 26 | PERCEPTIVE ADVISORS LLC | other | 555,555 |
| Aug 2, 22 | PERCEPTIVE ADVISORS LLC | other | 400,000 |
| Mar 25, 26 | PERCEPTIVE ADVISORS LLC | other | 400,000 |
| Aug 2, 22 | PERCEPTIVE ADVISORS LLC | other | 300,000 |
| Mar 25, 26 | PERCEPTIVE ADVISORS LLC | other | 300,000 |
Our MGTX Coverage
We haven't published any research on MGTX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MGTX Report →